Optical coherence tomography imaging is playing a growing role in ophthalmology diagnosis, but it is lacking something that other established imaging modalities have: a consensus “phantom” eye model to bench test image quality, say FDA researchers.
The agency wants to collaborate with others to address that issue. Funding awarded last year from FDA’s Critical Path Initiative is supporting efforts to build a consensus phantom model by...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?